Experts study whether DMTs lower MS relapse risk during reproductive therapy; a new study shows chronic MS lesions can be distinguished in a clinical setting, and a review highlights advancing care and outcomes for African Americans with multiple sclerosis.
These noteworthy MS news highlights and more are included in our May Bulletin below – a 30-day snapshot of global news & publications on MS research, treatment and care.
ECTRIMS Bulletins can be sent to you every month, delivered straight to your inbox, via our free subscription service. Simply select all “topics” that are of interest to you, and when one of those appears in our news & publication cycle you’ll be sure to hear from us.
Select MS News
Physicians Weekly | 23 May 2022
In women with multiple sclerosis and clinically isolated syndrome, continuing disease modifying therapy during assisted reproductive technologies appears to reduce the risk for relapse during this period of marked hormonal fluctuations and stressors
Multiple Sclerosis News Today | 22 June 2022
The risk of erectile dysfunction was about three times greater in men with multiple sclerosis (MS) compared with healthy men, according to a recent meta-analysis of published studies.
Neurology Advisor | 3 June 2022
Baseline neurofilament light chain (NfL) levels may be a biomarker of future lesion activity observed during magnetic resonance imaging (MRI) and relapse risk among patients with multiple sclerosis, according to study results presented at the 2022 Annual Meeting of the Consortium of Multiple Sclerosis Centers (CMSC) held from 1-4 June in Maryland.
Neuroscience News | 31 May 2022
Study reveals an association between signal detection theory, brain activation patterns, and subjective state fatigue. In those with multiple sclerosis, greater effects of fatigue were seen.
Neuroscience | 30 May 2022
Two recently published studies by UW Medicine researchers indicate that clinicians should offer non-pharmaceutical help for pain, fatigue, depression, or anxiety at the time of diagnosis for patients with multiple sclerosis, rather than wait.
MS News Today | 31 May 2022
The U.S. Department of Defense has awarded $3.9 million to fund clinical research to test the impact of a low-glycemic diet on physical, cognitive, and psychological function in people with multiple sclerosis.
Select MS Publications
Neurology | 14 June 2022
This narrative review highlights the nature and magnitude of the health disparities experienced by African Americans with MS and underscore the pressing need to increase knowledge about and understanding of MS disease manifestations in this group.
Annals of Neurology | 17 June 2022
These results of this study provide the first evidence that it is possible to distinguish chronic MS lesions in a clinical setting, hereby supporting with new biomarkers to develop and assess remyelinating treatments.
- Disability and Fatigue in Multiple Sclerosis: Can Rehabilitation Improve Them through a Structured Retraining Program?
Multiple Sclerosis International | 16 June 2022
A structured retraining exercise training program improves multiple sclerosis-related fatigue in the short and medium term. It can be an effective adjunct to fatigue management in the absence of specific pharmacological treatment to improve it.
- Clinically relevant profiles of myelin content changes in patients with multiple sclerosis: A multimodal and multicompartment imaging study
Multiple Sclerosis Journal | 16 June 2022
New study investigates the clinical relevance of individual profiles of cortical and white matter lesion myelin content changes combining magnetisation transfer imaging (MTI) and 11C-PiB-positron emission tomography (PET) in patients with multiple sclerosis (MS).
- The Sexual Dimorphism in Cerebrospinal Fluid Protein Content Does Not Affect Intrathecal IgG Synthesis in Multiple Sclerosis
MDPI | 16 June 2022
In light of the discrepancies between males and females in the onset and course of multiple sclerosis and of the effects of sex and age on CSF protein content and BCSFB permeability, this study aims to investigate whether sex and age have an impact on CSF analysis used to support the diagnosis of MS.
Science Direct | 13 June 2022
New study suggests that targeting the bone marrow niche presents an avenue to treat MS and other autoimmune disorders.